Clinical outcomes of HIV-infected patients hospitalized with bacterial community-acquired pneumonia

SummaryBackgroundThere are limited and conflicting data on clinical outcomes of community-acquired pneumonia (CAP) among HIV-infected patients.MethodsSecondary analyses of clinical outcomes of CAP were performed for 118 patients with HIV infection and 2790 patients without HIV infection enrolled in the Community-Acquired Pneumonia Organization (CAPO) international study. After adjustment for significant confounders, the effect of HIV infection on length of stay (LOS) and time to clinical stability (TCS) were examined by survival analyses and overall mortality and CAP-related mortality by logistic regression methods.ResultsAfter adjusting for significant confounders, hospitalized HIV-infected patients with CAP did not have longer times to reach clinical stability (HR 1.126; 95% CI 0.917–1.391; p = 0.251) or longer stays in the hospital (HR 1.191, 95% CI 0.979–1.449; p = 0.080). In addition, HIV infection did not significantly influence overall mortality rates (OR 1.205, 95% CI 0.686–2.116; p = 0.517) or CAP-related mortality rates (OR 1.338; 95% CI 0.623–3.725; p = 0.355).ConclusionThe presence of HIV infection did not influence the clinical outcomes of CAP among patients assessed at CAPO centers. It is not intended that our results be extrapolated to populations receiving limited healthcare for advanced HIV disease, malnourishment and parasitic diseases.